spacer
home > epc > autumn 2008 > commitment issues
PUBLICATIONS
European Pharmaceutical Contractor

Commitment Issues

As with all regulations, some are easier to follow than others. There are always going to be scenarios Ďat the marginsí where any regulation will struggle to define the correct procedure or process for dealing with a specific issue, or may appear to be in conflict with some other aspect of best practice.

This has been amply illustrated within the laboratory sector in recent times, with the delayed implementation of General Chapter <467> Residual Solvents of the United States Pharmacopoeia Ė National Formulary (USP-NF). This proposed revision to the USP-NF had first been scheduled for introduction on 1st January 2007, only for implementation to be delayed until 1st July 2007, and then further delayed with an implementation date of 1st July 2008.

BACKGROUND TO CHAPTER <467>

The essential rationale behind USP <467> is an attempt to harmonise test standards for residual solvents for medicines sold in the US in accordance with a model already adopted by the European Pharmacopeia. It aims to prescribe standard test methods for three classes of solvent. These are:

  • Class 1 solvents, a defined list of chemicals that are known or suspected to be human carcinogens
  • Class 2 solvents, a defined list known to be animal carcinogens or to exhibit other toxicity
  • Class 3 solvents, a defined list of chemicals having low toxic potential

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Philip Payne is Business Development Manager for RSSL Pharma. He joined from Italian API producer, Steroid, where he was General Manager with responsibility for sales, procurement, production and analysis. Fluent in Italian, French and English, and with broad experience of research and production, Philip now assists RSSL Pharma in promoting its analytical and training services more widely across Europe, in addition to the UK and Ireland.
spacer
Philip Payne
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Mr Turhan Ozen Chief Cargo Officer at Turkish Airlines elected to the International Air Cargo Association (TIACA) Committee

Turhan Ozen, serving as Chief Cargo Officer at the global brand Turkish Airlines, was elected to the International Air Cargo Association (TIACA) Committee, the joint voice of the industry that aims to enhance the air cargo profile with intensive efforts towards the global standards.
More info >>

White Papers

Advanced BioDesign Outlines Solutions

Advanced BioDesign

Launching an immunisation programme is an important experimental step that needs care. With Advanced BioDesign, clients may develop and produce antibodies according to customers' specific needs. The company offers: real support and advice from a dedicated team all along your project; large and modern SPF animal facility; ethical treatment of animals. The evaluation of a project is free-of-charge and with no obligation. Dedicated project managers will work with clients from the beginning to the end of a custom antibody project to ensure the highest level of quality and service.
More info >>

 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: itís where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on todayís hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement